Association of matrix metalloproteinase 3 and endogenous inhibitors with inflammatory markers in mitral valve disease and calcification
- 9 October 2018
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 45 (6) , 2135-2143
Abstract
Calcific mitral valve stenosis (MVS) is a common disease characterized by extensive remodeling of the extracellular matrix via matrix metalloproteinases (MMPs). The mechanism of calcification due to extensive matrix remodeling remains unclear. In this study, we investigated the relationship between MMP-3, tissue inhibitors of metalloproteinases (TIMPs) as well as pro-inflammatory cytokines and the phenomenon of calcification in MVS. 212 patients having rheumatic mitral stenosis (RMS) and 155 healthy control subjects were recruited in the Cardiology Department of La Rabta Hospital University. Levels of MMP-3, TIMPs, IL-6 and TNF-α were measured by ELISA sandwich assay, hs-CRP was measured by immunoturbidimetry. Plasma levels of MMP-3, TIMP-1 and MMP-3/TIMP-2 ratio were lower only in RMS women in comparison to the control group. Calcification degree correlated positively with MMP-3 in women and men. In addition, calcification was correlated positively with MMP-3/TIMPs ratio in women patients. The inflammatory parameters were positively associated with extracellular matrix turnover biomarkers in men patients. In patients, the level of MMP-3 was increased in men and women with a calcification score ≥ 5. In addition, MMP-3 level predicted the occurrence of calcification. At ROC curves analysis, the cut-off MMP-3 level was in women was 9.21 ng/ml (sensitivity 51.1%, specificity 89.3%) and in men was 12.84 ng/ml (sensitivity 78.6%, specificity 77.8%). The high levels of MMP-3 and the biomarkers of inflammation contribute to valvular remodeling and calcification of the mitral valve.Keywords
This publication has 36 references indexed in Scilit:
- Serum Levels of IL-17 and IL-23 in Patients With Rheumatic Mitral StenosisMedicine, 2016
- Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and PhosphateCirculation Research, 2011
- Aberrant Inflammatory Response to Streptococcus pyogenes in Mice Lacking Myeloid Differentiation Factor 88The American Journal of Pathology, 2010
- Transforming Growth Factor-β1 Induces Tissue Inhibitor of Metalloproteinase-1 Expression via Activation of Extracellular Signal-Regulated Kinase and Sp1 in Human Fibrosarcoma CellsMolecular Cancer Research, 2006
- Targeted Overexpression of Noncleavable and Secreted Forms of Tumor Necrosis Factor Provokes Disparate Cardiac PhenotypesCirculation, 2004
- Percutaneous transvenous mitral valvulotomy normalizes elevated circulating levels of tumor necrosis factor-α and interleukin-6 in mitral stenosis with heart failureThe American Journal of Cardiology, 2003
- Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves.2002
- Matrix MetalloproteinasesJournal of Biological Chemistry, 1999
- Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wallJournal of Vascular Surgery, 1994
- Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation.Heart, 1988